date:Nov 29, 2012
ini at the University of Caen, France.
The first part of EFSAs review had concluded that the design, reporting and analysis of the study, as outlined in the paper, are inadequate.
It said: The numerous issues relating to the design and methodology of the study, as described in the paper, mean that no conclusions can be made about the occurrence of tumours in the rats tested.
Weaknesses
In its second ruling on the study EFSA said member states identified many of the same weaknesses in the met